Henry Schein Inc HSIC Financial and Strategic SWOT Analysis Review [Report Updated: 04042019] Prices from USD $106

02:58 EST 15 Jan 2020 | BioPortfolio Reports

Henry Schein Inc HSIC Financial and Strategic SWOT Analysis Review provides you an indepth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

Business description A detailed description of the company's operations and business divisions.

Corporate strategy Analyst's summarization of the company's business strategy.

SWOT Analysis A detailed analysis of the company's strengths, weakness, opportunities and threats.

Company history Progression of key events associated with the company.

Major products and services A list of major products, services and brands of the company.

Key competitors A list of key competitors to the company.

Key employees A list of the key executives of the company.

Executive biographies A brief summary of the executives' employment history.

Key operational heads A list of personnel heading key departments/functions.

Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.

Key manufacturing facilities A list of key manufacturing facilities of the company.

Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semiannual financial statements published by the company for 5 interims history.


Henry Schein Inc Henry Schein is a provider of health care products and services to dental and medical practitioners. Its product portfolio consists of dental and medical products, software and technology and other valueadded services. The company distributes both generic and branded drugs. Henry Schein supplies its products and provides services to dental practitioners and laboratories, physician practices, and government and other institutions through a centralized and automated distribution network. The company, along with its subsidiaries, operates in Germany, Canada, France, Switzerland, the UK and the US. It also manages affiliates in Iceland, Saudi Arabia and Turkey. Henry Schein is headquartered in New York, the US.

Henry Schein Inc Key Recent Developments

Mar 12,2019 Henry Schein to showcase comprehensive portfolio of solutions for Health Care Professionals at the 38th International Dental Show

Feb 26,2019 Henry Schein named one of the 2019 World's most ethical companies by Ethisphere

Feb 21,2019 Zahn Dental Announces New Solutions, Live Educational Events, and Introduction of Zahn Digital Solutions at LMT Lab Day, February 21 23, in Chicago, IL

Feb 21,2019 Henry Schein One Unveils Entertaining Patient Theater Experience With New Booth At Chicago Midwinter Dental Meeting

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Original Article: Henry Schein Inc HSIC Financial and Strategic SWOT Analysis Review [Report Updated: 04042019] Prices from USD $106


More From BioPortfolio on "Henry Schein Inc HSIC Financial and Strategic SWOT Analysis Review [Report Updated: 04042019] Prices from USD $106"

Quick Search

Relevant Topics

Dentistry is the study, management and treatment of diseases and conditions affecting the mouth, jaw, teeth and their supporting tissues (Oxford Medical Dictionary) The work of a dentist ranges from regular patient check-up to orthodontics and surgery....

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...